MESA LABORATORIES INC /CO
Cash Flow Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $6.7M | $-2.0M | $-254.2M | $930.0K | $1.9M | $3.3M | $1.8M | $7.5M |
| Depreciation & Amortization | — | — | — | $33.8M | $25.1M | $17.7M | $13.0M | $9.4M |
| Depreciation | $5.3M | $5.4M | $4.2M | $4.3M | $3.3M | $3.0M | $2.2M | $2.3M |
| Amortization | $18.0M | $19.1M | $27.3M | $28.8M | $21.8M | $14.5M | $10.6M | $7.1M |
| Stock-Based Compensation | $17.9M | $13.1M | $11.9M | $12.5M | $11.4M | $9.3M | $5.5M | $4.2M |
| Net Cash from Operating Activities | $42.8M | $46.8M | $44.1M | $28.0M | $39.2M | $37.1M | $27.0M | $30.6M |
| Investing Activities | ||||||||
| Capital Expenditures | $3.3M | $4.2M | $2.6M | $4.5M | $4.4M | $2.0M | $1.5M | $1.3M |
| Business Acquisitions | $0 | $0 | $78.7M | $5.0M | $300.8M | $0 | $184.1M | $4.8M |
| Net Cash from Investing Activities | $-3.3M | $-4.5M | $-81.3M | $-9.5M | $-305.2M | $-2.0M | $-185.6M | $-3.9M |
| Financing Activities | ||||||||
| Dividends Paid | $3.5M | $3.5M | $3.4M | $3.4M | $3.3M | $3.2M | $2.7M | $2.5M |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-41.9M | $-44.5M | $32.8M | $-33.3M | $52.6M | $146.2M | $231.3M | $-21.7M |
| Net Change in Cash | $-393.0K | $-893.0K | $-4.7M | $-16.4M | $-214.5M | $182.5M | $71.2M | $4.7M |
| Free Cash Flow | $39.6M | $42.6M | $41.6M | $23.4M | $34.8M | $35.1M | $25.5M | $29.3M |